Alnylam Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2836 www.alnylam.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts - Jun 9th, 2026 11:03 am
Bloom Energy, Astera Labs, Alnylam, Reddit Could Be Among Next Adds to S&P 500 - Jun 8th, 2026 3:06 pm
Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer - Jun 8th, 2026 5:00 am
Why Is Sarepta Therapeutics (SRPT) Down 19.9% Since Last Earnings Report? - Jun 5th, 2026 9:30 am
Alnylam Pharmaceuticals (ALNY) Valuation Check As US$2b AI RNAi Collaboration With Inceptive Nucleics Gains Attention - Jun 5th, 2026 5:13 am
Stocks Rebound on Strength in Banks and Managed Healthcare - Jun 4th, 2026 2:32 pm
JPMorgan Says Buy the Dip in These 2 Large-Cap Biotech Stocks - Jun 4th, 2026 11:30 am
Alnylam Bets on AI for Speedy RNAi Drug Discovery and Development - Jun 4th, 2026 9:27 am
Stocks Mixed as Tech Weakness Weighs - Jun 4th, 2026 9:16 am
Weakness in Technology Stocks Pressures Stock Indexes - Jun 4th, 2026 8:10 am
Alnylam, Inceptive ink AI deal potentially worth $2B - Jun 4th, 2026 4:42 am
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics - Jun 3rd, 2026 2:45 pm
Are Options Traders Betting on a Big Move in Alnylam Stock? - May 30th, 2026 12:55 pm
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside - May 28th, 2026 2:27 pm
Citi Initiates Alnylam (ALNY) With Buy Rating - May 25th, 2026 12:09 pm
JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms - May 20th, 2026 1:29 pm
StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls - May 19th, 2026 7:34 am
Immunic appoints Biogen, Cubist veteran Mike Bonney as board chair ahead of key MS trial readout - May 19th, 2026 7:33 am
Alnylam Issues 2025 Corporate Responsibility Report - May 19th, 2026 6:30 am
How Investors Are Reacting To Alnylam Pharmaceuticals (ALNY) New HELIOS-B Vutrisiran Data And Real-World Study - May 18th, 2026 12:14 pm